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Determinants of E2-ubiquitin 
conjugate recognition by RBR E3 
ligases
Luigi Martino  1, Nicholas R. Brown1,3, Laura Masino2, Diego Esposito1 & Katrin Rittinger  1
RING-between-RING (RBR) ubiquitin ligases work with multiple E2 enzymes and function through an 
E3-ubiquitin thioester intermediate. The RBR module comprises three domains, RING1, IBR and RING2 
that collaborate to transfer ubiquitin from the E2~Ub conjugate, recognised by RING1, onto a catalytic 
cysteine in RING2 and finally onto the substrate in a multi-step reaction. Recent studies have shown 
that RING1 domains bind E2~Ub conjugates in an open conformation to supress ubiquitin transfer 
onto lysine residues and promote formation of the E3 thioester intermediate. However, how the 
nature of the E2 influences the ubiquitin transfer process is currently unclear. We report here a detailed 
characterization of the RBR/E2-conjugate recognition step that indicates that this mechanism depends 
on the nature of the E2 enzyme and differs between UbcH5 and UbcH7. In the case of UbcH5~Ub an 
interaction with ubiquitin is necessary to stabilize the transfer complex while recognition of UbcH7~Ub 
is driven primarily by E2-RING1 contacts. Furthermore our analysis suggests that RBRs, in isolation and 
in complex with ubiquitin-loaded E2s, are dynamic species and that their intrinsic flexibility might be a 
key aspect of their catalytic mechanism.
Attachment of ubiquitin to a protein target is a crucial post-translational modification that regulates a plethora 
of cellular signalling pathways. It requires the sequential action of three enzymes: ubiquitin activating enzymes 
(E1), ubiquitin conjugating enzymes (E2) and ubiquitin ligases (E3)1. E3s confer substrate specificity and catalyse 
attachment of ubiquitin onto a lysine residue of the target protein (mono-ubiquitination or chain initiation), or 
onto a lysine or the N-terminal methionine of another ubiquitin molecule to form polyubiquitin chains. E3s can 
be classified into two major groups: RING ligases that transfer ubiquitin directly from the E2 conjugate to the 
target molecule and the thioester-forming E3s, HECT and RBR ligases that function through an E3~ubiquitin 
(~indicates a thioester bond) thioester intermediate2–9. RBR ligases represent the newest addition to the E3 ligase 
family and their mechanism of action incorporates features of RING and HECT ligases8. The catalytic RBR 
module comprises three zinc-binding motifs: a RING1 domain (the E2-interacting portion) followed by an IBR 
domain and a RING2 domain that contains the catalytic cysteine (Fig. 1A,B). While the RBR module is well con-
served (Fig. 1C), most RBR E3s contain accessory domains N- or C-terminal to the RBR domain, thereby increas-
ing protein complexity and allowing for regulation of enzymatic activity, for example through auto-inhibitory 
interactions as observed in HHARI and Parkin10,11. For other RBRs regulation of catalytic activity is not necessar-
ily achieved through auto-inhibition. For example, even though HOIP in isolation is auto-inhibited by its UBA 
domain, which is relieved by interaction with HOIL and SHARPIN components of the LUBAC machinery12–14, it 
is now well established that complex formation between LUBAC components is constitutive15–18. Instead, LUBAC 
activity is kept in check by the presence of DUBs, such as OTULIN and CYLD, bound directly (OTULIN) or 
indirectly (CYLD via SPATA2 protein) to the PUB domain of HOIP19–30.
RBR ligases function with multiple E2s, including UbcH5 (UBE2D) isoforms and UbcH7 (UBE2L3), the latter 
of which has been suggested to be the physiologically relevant E2 for LUBAC and possibly other RBRs5,8,31–33. 
These E2s are mechanistically distinct and while UbcH5 can transfer ubiquitin onto both, lysine and cysteine 
residues, UbcH7 is strictly cysteine-reactive and hence only functions with RBR and HECT ligases, though it is 
capable to form stable complexes with RING domains8,34. In isolation, UbcH5~Ub exists in multiple conforma-
tions but preferentially populates open states35. However, only the closed conformation is competent for ubiquitin 
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transfer onto a lysine, which requires interaction with canonical RING domains for its stabilisation36–39. In con-
trast, an open E2~Ub state is stabilized in conjunction with RING1 domains found in RBR E3s40. This mode of 
interaction suppresses lysine reactivity and hence favours transthiolation to form the E3~ubiquitin intermediate. 
Unlike UbcH5, the UbcH7~Ub conjugate populates closed states to a considerable extent in isolation. However, 
despite its lack of lysine reactivity, UbcH7~Ub also binds RING1 domains in an open conformation as recently 
shown for HHARI40–42.
Although biochemical studies have advanced our understanding of the mechanistic features of ubiquitin 
transfer by RBR ligases considerably, structural information on active RBR/E2~Ub complexes is sparse and lim-
ited to the crystal structure of the HOIP RBR/UbcH5B-Ub complex (-indicates a stable thioester mimetic, an 
isopeptide, used for crystallization and biophysical experiments)43. This structure (PDB 5EDV) unveiled novel 
insights into the molecular details of the E2/E3 interaction and provided a model for ubiquitin transfer from E2 
to the catalytic cysteine in RING2. Interestingly, the crystal structure of this complex contains two molecules 
of HOIP-RBR in the asymmetric unit arranged in a domain swapped fashion where each RBR domain binds 
one molecule of UbcH5B-Ub, plus a free ubiquitin molecule that has been suggested to play an allosteric role 
(see Supplementary Figure S1A–B). Each RBR molecule adopts an extended conformation (see Supplementary 
Figure S1C), with RING1 recognising E2 via a surface that is similar, but not identical to the canonical E2/RING 
interface. UbcH5B-Ub is bound in an open conformation with the ubiquitin contacting the two helices connect-
ing RING1 and IBR. Additional RBR/E2-Ub contacts are made by the IBR-RING2 linker and RING2 from the 
adjacent complex. However, this intricate arrangement is believed to be a crystallisation artefact, and instead it 
was suggested that the catalytically relevant unit is formed by half of each of the N- and C-terminal portions of the 
two RBR molecules bound (see Supplementary Figure S1D, in here referred to as the “compact conformation”). 
In addition to this structure of an active RBR/E2-Ub complex, two crystal structures of HHARI in complex with 
UbcH7-Ub were recently described (PDB 5UDH and 5TTE)41,42. Although bound to an E2-Ub thioester mimetic, 
HHARI adopts an autoinhibited conformation in these structures and the catalytic cysteine in RING2 remains 
occluded by the Ariadne domain. The two structures were solved in different crystal forms and although the 
overall architecture of the complex is very similar, they differ in the position of the ubiquitin molecule. In both 
structures UbcH7-Ub interacts with HHARI in an open conformation but in one structure (PDB 5TTE) ubiquitin 
contacts the UBA domain of the same HHARI molecule in a non-canonical manner, whereas in the other com-
plex (PDB 5UDH), ubiquitin contacts the UBA domain of a symmetry related molecule using an interface that 
resembles a canonical UBA-ubiquitin interaction41,42. Although these structures shed light on E2~Ub recognition 
Figure 1. Domain organisation and sequence alignment of RBRs. (A) Schematic representation of the domain 
organisation of some RBR E3 ubiquitin ligases. The RBR domains, comprising a RING1, IBR and a RING2 
domain are coloured in purple while extra domains are indicated in cyan. (B) The RBR constructs used in 
this study are reported; for some extra domains had to be included in the recombinant proteins to improve 
solubility/stability or to preserve enzymatic activity. (C) Primary sequence alignment of RBR domains of human 
HHARI (Uniprot Q9Y4X5), HOIP (Q96EP0), TRIAD3A (Q9NWF9) and RNF144A (P50876) performed by 
using ClustalOWS and displayed by using JalView program (www.jalview.org). Black stars indicate the residues 
that are involved in Zinc coordination. The catalytic cysteine residues (C357 for HHARI, C885 for HOIP, C688 
for TRIAD3A and C198 for RNF144A) are indicated by a red star.
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by RING1, the presence of the Ariadne domain keeps RING2 away from the E2~Ub conjugate and hence does not 
provide insight into the active RBR/E2~Ub conformation during the transthiolation step.
The recently described Parkin/phosphoUb complex structures present a partially active form, in which minor 
conformational changes in the E3 are responsible for the creation of multiple ubiquitin binding sites that may 
accommodate E2~Ub conjugates44,45. Based on these structures a model was proposed, in which Parkin catalyses 
ubiquitin transfer in trans and where an E2~Ub conjugate could bridge two molecules of E3 in a fashion that 
resembles the arrangement observed in the HOIP/UbcH5B-Ub structure45.
In light of these novel structural insights into RBR/E2~Ub complexes and the observation that RING1 
domains bind their E2~Ub conjugates in an open conformation in contrast to canonical RING domains that 
stabilise a closed form, we asked if there are fundamental differences in the way RBRs recognise lysine-reactive 
UbcH5 enzymes versus cysteine-reactive UbcH7 and how any such differences might influence their catalytic 
activity. To address these questions we performed an extensive biochemical and biophysical analysis of the RBR 
domains of HHARI, HOIP, TRIAD3A and RNF144A, in the absence of any potential auto-inhibitory interactions. 
We characterised their interaction with UbcH7 and UbcH5A, which unveiled what may be a more general fea-
ture of RBRs: they all form a strong complex with UbcH7 that is not significantly strengthened upon ubiquitin 
conjugation. In contrast, no interaction can be detected with isolated UbcH5 and even ubiquitin conjugation 
only leads to a stable complex for a subset of RBRs. However, these differences in complex formation do not 
lead to obvious differences in catalytic activity, which may indicate that the only element driving interaction 
with ubiquitin-loaded E2s is the need for suppression of lysine reactivity of E2s other than UbcH7. Moreover, 
to provide novel structural insight in the RBR/E2-Ub complexes investigated, we performed an extensive SAXS 
analysis, which revealed that the RBRs and their complexes with UbcH7-Ub and/or UbcH5A-Ub are monomeric 
in solution and are highly flexible entities.
Results
The RBR domains of HHARI, HOIP, TRIAD3A and RNF144A. For this study, the RBR domains of 
HHARI, HOIP, TRIAD3A and RNF144A were chosen as representatives of this E3 family (Fig. 1B). For HHARI-
RBR, the UBA domain N-terminal to RING1 was included to improve its solubility10 while for HOIP-RBR, the 
C-terminal LDD domain that is required for catalytic activity was retained12–14. Less is known about TRIAD3A 
and RNF144A and sequence alignments were used to define RBR domain boundaries (Fig. 1C). For RNF144A 
the RBR domain is predicted to span the first 250 residues of the protein, with a trans-membrane element (TM) 
in the C-terminus of the protein. The 250 residue construct lacking the trans-membrane element was soluble 
and active and used for this study. The RBR domain of TRIAD3A, predicted to span residues 510 to 714, did 
not yield a soluble protein; but extending the construct to residue 801 improved solubility. Interestingly, the pri-
mary sequence of this C-terminal extension is rich in Cys and His residues and we wondered if they may form 
an additional zinc binding site. To test this hypothesis, native mass spectroscopy was carried out on a construct 
encompassing the RING2 of TRIAD3A plus the C-terminal extension (residues 674–801). This analysis indicated 
the presence of three zinc ions (see Supplementary Figure S2A,B): two of them likely associated with RING2 and a 
third zinc ion probably bound to the C-terminal extension. We also tested a slightly shorter construct trimmed at 
the C-terminus to residue 783 (see Supplementary Figure S2C,D) and we found that it was still able to bind three 
zinc ions. At present, we do not understand the relevance of this additional zinc-binding domain (Zn-BD) but it 
is included in the construct referred to as TRIAD3A-RBR.
The interaction between RBRs and E2 enzymes and their ubiquitin conjugates. To gain insight 
into the propensity of different E2 enzymes to bind RBR domains we tested their ability to bind unconjugated 
UbcH7 (Fig. 2A,E,I,M) and UbcH5A (Fig. 2C,G,K,O). Intriguingly, we could not detect binding of UbcH5A 
to any of the RBRs tested, whilst a strong interaction was observed with UbcH7. The strength of complex for-
mation ranges between 0.4 μM and 2.3 μM, with a well-conserved thermodynamic signature: the association is 
largely entropy driven with a small positive enthalpy (Table 1). The observed affinity for the HHARI/UbcH7 
interaction agrees well with a previous study by Duda et al.10 but is about 10-fold weaker than a recent study, 
which also reported an affinity of 20 μM for the HHARI/UbcH5B interaction41. At present it is not clear what 
the reason for these apparent differences is and we can only speculate that it might be linked to differences in the 
protein fragments used. Interestingly, conjugation of ubiquitin to UbcH7 provides only a small increase in affinity 
(Fig. 2B,F,J,N and Table 1) and even though the sign of the enthalpy changes for some of the RBRs tested (HHARI 
and RNF144A) the overall thermodynamic signatures remain conserved and binding is largely entropy driven. 
In contrast, UbcH5A-Ub shows a clear 1:1 interaction only with the RBR domains of HOIP and HHARI with Kd 
values around 4.5 μM, somewhat weaker than those for UbcH7-Ub. Titration of TRIAD3A and RNF144A with 
UbcH5A-Ub showed only a clear heat change during the first few peaks of the titration and saturation was reached 
after a few injections corresponding to an apparent molar ratio of E3/E2-Ub of about 0.2 (see Supplementary 
Figure S3A,B). To test if this sub-stoichiometric binding event might be due to a non-specific interaction we 
carried out titrations at increased salt concentration (300 mM NaCl instead of 150 mM). This condition indeed 
suppressed any apparent interaction (Fig. 2L,P and see Supplementary Figure S3C,D). Furthermore, in agreement 
with these ITC titrations we could not detect complex formation for TRIAD3A and RNF144A with UbcH5A-Ub 
during SEC-SAXS analysis (see below). Based on these observations, we conclude that under our experimental 
conditions TRIAD3A and RNF144A are not able to form a stable complex with UbcH5A-Ub.
Taken together, these results suggest that for the interaction of UbcH5A~Ub with HHARI or HOIP, the ubiq-
uitin moiety plays an important role in the formation of the RBR/E2~Ub complex, in agreement with the HOIP/
UbcH5B-Ub structure that shows extensive contacts between ubiquitin and the RBR domain43. In contrast, the 
lack of a significant increase in affinity of RBRs for the UbcH7-Ub conjugate indicates that in this case recognition 
is driven primarily by contacts between RING1 and the E2. To test this model and further evaluate the role of IBR 
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and RING2 domains in complex formation, the ITC experiments were repeated with RBR fragments contain-
ing only the RING1 domains plus the adjacent linker helices (see Supplementary Figure S4 and Table 1). These 
fragments are indeed able to bind to both, UbcH7 and UbcH7-Ub, with affinities similar to those observed for 
Figure 2. ITC analysis of the interaction of RBRs with UbcH7, UbcH5A and their ubiquitin conjugates. 
Isothermal titration calorimetry was used to measure the affinities of RBRs for UbcH7, UbcH5 and their 
ubiquitin conjugates. Experiments are reported for HHARI (A–D), HOIP (E–H), TRIAD3A (I–L) and 
RNF144A (M–P). Raw data (top) and normalized binding curves (bottom) are reported. Black squares indicate 
the normalized heat of interaction obtained per injection, while a black curve represents the best fit obtained by 
non-linear least-squares procedures based on a 1:1 binding model. Experiments were carried out in presence of 
150 mM NaCl, apart from those reported in panels L and P, which were performed in presence of 300 mM NaCl 
to abolish non-specific interaction (see supplementary Figure S3).
www.nature.com/scientificreports/
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interaction with the entire RBR domains. On the other hand, no interaction could be detected with UbcH5A-Ub 
under the experimental conditions, indicating that the interaction must be weaker than ~50 µM. These data sup-
port a model where the interaction with UbcH7~Ub is largely driven by the recognition between the E2 and 
RING1 with only a small contribution from additional contacts of the RBR with ubiquitin. In contrast, complex 
formation with UbcH5A~Ub is absolutely dependent on the ability of HOIP and HHARI to contact the ubiquitin 
moiety conjugated to the E2.
Relationship between RBR/E2~UB complex formation and catalytic activity. Given these con-
trasting behaviours in recognition of UbcH5A~Ub and UbcH7~Ub conjugates by RBRs, we asked if they trans-
late into differences in ubiquitination activity. HOIP forms free linear polyubiquitin chains in the absence of 
a protein substrate, whereas for the other RBRs we used auto-ubiquitination as a proxy readout for catalytic 
activity. It is important to note that the apparent activity seen in ubiquitination assays depends strongly on the 
reaction conditions used (e.g. temperature, concentrations of reactants). Since we wanted to compare the activity 
of four different E3s we had to optimise experimental conditions and found that the ratio between E2 and E3 
concentrations is a very sensitive parameter, at least for some E3s (see Supplementary Figure S5). Our experi-
ments showed that a good level of auto-ubiquitination could be detected across the same time range when the 
concentration of E3 was higher than the E2. Interestingly, the ratio between E2 and E3 does not appear to affect 
the activity of HOIP, but has a clear effect on that of HHARI, TRIAD3A and RNF144A. In particular the effect on 
HHARI is profound with long chains favoured when the assay is performed using a concentration of E2 higher 
than of E3; on the other hand when the assay is performed with concentrations of E2 lower than E3, or when 
the two enzymes have the same concentration, shorter chains are formed. On the basis of these tests we have 
chosen to perform the assays described in Fig. 3 with excess of E3, using the following concentrations: 0.5 μM 
E1, 2 µM E2, 5 µM E3 and 50 µM ubiquitin. Under these conditions, HHARI, HOIP and RNF144 showed clear 
ubiquitination activity with a slightly higher activity for UbcH7 with HHARI and RNF144A whereas linear chain 
formation by HOIP was slightly increased with UbcH5A. The results observed for HHARI and HOIP agree well 
with previous reports8,10,12,41. In contrast, no clear activity was detected for TRIAD3A. However, when the assays 
were repeated with a TRIAD3A construct containing a GST-tag, clear auto-ubiquitination was observed (see 
Supplementary Figure S6A). This difference may be due to the higher number of lysine residues available in this 
Interactions n Kd (uM)
ΔH Kcal/
mol
−TΔS Kcal/
mol
ΔG Kcal/
mol
HHARI-RBR/UbcH7 0.9 ± 0.1 0.41 ± 0.05 1.8 ± 0.2 −10 ± 0.6 −8.2 ± 0.8
HHARI-RBR/UbcH7-Ub 0.9 ± 0.1 0.20 ± 0.01 −2.3 ± 0.2 −6.6 ± 0.7 −8.9 ± 0.9
HHARI-Ring1/UbcH7 0.8 ± 0.1 0.21 ± 0.01 4.2 ± 0.5 −13.2 ± 0.4 −9.0 ± 0.9
HHARI-Ring1/UbcH7-Ub 0.8 ± 0.2 0.12 ± 0.01 3.9 ± 0.4 −13.3 ± 0.6 −9.4 ± 0.9
HHARI-RBR/UbcH5A No binding detected
HHARI-RBR/UbcH5A-Ub 0.8 ± 0.1 4.5 ± 0.4 −3.7 ± 0.4 −3.4 ± 0.2 −7.1 ± 0.6
HHARI-Ring1/UbcH5A-Ub No binding detected
HOIP-RBR/UbcH7 0.8 ± 0.2 2.3 ± 0.2 0.8 ± 0.1 −8.3 ± 0.4 −7.5 ± 0.6
HOIP-RBR/UbcH7-Ub 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 −8.9 ± 0.6 −8.1 ± 0.8
HOIP-Ring1/UbcH7 1.0 ± 0.1 4.8 ± 0.5 1.4 ± 0.2 −8.5 ± 0.5 −7.1 ± 0.7
HOIP-Ring1/UbcH7-Ub 0.9 ± 0.2 4.3 ± 0.4 1.1 ± 0.2 −8.3 ± 0.5 −7.2 ± 0.7
HOIP-RBR/UbcH5A No binding detected
HOIP-RBR/UbcH5A-Ub 0.9 ± 0.1 4.3 ± 0.3 −8.2 ± 0.5 1.0 ± 0.1 −7.2 ± 0.7
HOIP-Ring1/UbcH5A-Ub No binding detected
TRIAD3A-RBR/UbcH7 1.0 ± 0.1 2.0 ± 0.1 1.8 ± 0.7 −9.4 ± 0.1 −7.6 ± 0.8
TRIAD3A-RBR/UbcH7-Ub 0.9 ± 0.1 2.4 ± 0.1 3.7 ± 0.3 −11.2 ± 0.5 −7.5 ± 0.9
TRIAD3A-Ring1/UbcH7 0.8 ± 0.2 3.2 ± 0.2 4.5 ± 0.3 −11.8 ± 0.6 −7.3 ± 0.9
TRIAD3A-Ring1/UbcH7-Ub 0.8 ± 0.2 4.3 ± 0.3 3.6 ± 0.4 −10.8 ± 0.2 −7.1 ± 0.7
TRIAD3A-RBR/UbcH5A No binding detected
TRIAD3A-RBR/UbcH5A-Ub No binding detected
TRIAD3A-Ring1/UbcH5A-Ub No binding detected
RNF144A-RBR/UbcH7 0.9 ± 0.1 1.0 ± 0.1 1.7 ± 0.2 −9.7 ± 0.5 −8.0 ± 0.8
RNF144A-RBR/UbcH7-Ub 0.8 ± 0.2 0.52 ± 0.04 −0.9 ± 0.1 −7.5 ± 0.7 −8.4 ± 0.9
RNF144A-Ring1/UbcH7 0.8 ± 0.2 2.2 ± 0.2 3.5 ± 0.4 −11.1 ± 0.6 −7.5 ± 0.9
RNF144A-Ring1/UbcH7-Ub 0.8 ± 0.1 1.0 ± 0.1 2.7 ± 0.4 −10.7 ± 0.5 −8.0 ± 0.8
RNF144A-RBR/UbcH5A No binding detected
RNF144A-RBR/UbcH5A-Ub No binding detected
RNF144A-Ring1/UbcH5A-Ub No binding detected
Table 1. ITC-derived thermodynamic parameters for the association of HHARI, HOIP, TRIAD3A and 
RNF144A RBR and Ring1 domains with UbcH7, UbcH5A and their ubiquitin conjugates. Each experiment was 
repeated multiple times and the average values reported with their standard deviation.
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construct or could suggest that GST-induced dimerization increases activity. To characterise the type of ubiquitin 
modification formed (multi-mono or ubiquitin chain formation) ubiquitination assays were carried out with 
UbcH7 and lysine-less ubiquitin (Ub-K0). These experiments show that TRIAD3A and RNF144A mainly per-
form multi-mono ubiquitination (see Supplementary Figure S6B and D). In addition, TRIAD3A ubiquitination 
assays shows accumulation of some di-ubiquitin, which is mainly K63-linked, (Fig. 3C and see Supplementary 
Figure S6A–C). In sum, these experiments indicate that there is no clear link between the affinity of a given 
E2~Ub conjugate for an RBR and activity and hence that formation of a stable E3/E2~Ub complex is not required 
for catalytic activity. The same conclusion was recently drawn based on the analysis of HHARI41.
The isolated RBR domains and their E2~Ub complexes are elongated species. Given that no 
structural information is currently available for an active RBR/E2-Ub complex other than HOIP43, we performed 
size exclusion chromatography coupled with SAXS analysis (SEC-SAXS) on all four RBRs in isolation and in com-
plex with UbcH7-Ub and UbcH5A-Ub to gain novel low resolution structural insight into their conformation. 
The chromatographic profiles (see Supplementary Figure S7) are consistent with the assumption that the com-
plexes of HHARI, HOIP, TRIAD3A and RNF144A with UbcH7-Ub and HHARI and HOIP with UbcH5A-Ub 
co-migrate as one species on the column indicating that, at the concentration used for the experiment, stable 
RBR/E2~Ub complexes are formed. In agreement our ITC results, no complex formation was observed for 
TRIAD3A and RNF144A with UbcH5A-Ub.
Averaged SAXS curves, corrected for the solvent effect, were obtained for all the samples by following the 
procedures described in materials and methods (Fig. 4A,D,G,J). The radius of gyration (Rg) was obtained by 
Guinier analysis of the region of the curves at low q value and Dmax and Volume of Porod were evaluated by the 
distance distribution function (P(r)) (Fig. 4C,F,I,L). The analysis of the normalized Kratky plots (Fig. 4B,E,H,K) 
reveals some interesting properties of the samples: in all cases the maxima of the plots are shifted from the typical 
values expected for globular proteins (I(q)/I(0)·(q·Rg)2 = 1.104, q·Rg = 1.73, indicated by dashed cross lines in 
Fig. 4B,E,H,K to higher values indicating the presence of asymmetric particles in solution46–48. The asymmetry of 
the systems is also evident from the shape of the distance distribution function (P(r)) where distances larger than 
the Rg are extensively populated, suggesting that both, the RBRs and their complexes with E2-Ub, are elongated 
Figure 3. Auto-ubiquitination assays of RBRs with UbcH7 and UbcH5A. Coomassie-stained reducing 
SDS-gels of auto-ubiquitination assays for HHARI-RBR (A), HOIP-RBR (B), TRIAD3A-RBR (C) and 
RNF144A-RBR (D). The concentration of RBR used was 5 μM, whilst the concentrations of E1, E2 and Ub 
were 0.1, 2 and 50 μM, respectively. 10 mM ATP was added to start the reaction and samples were taken 
after 10, 30 and 60 minutes incubation at room temperature. Red and blue arrowheads indicate UbcH7 and 
UbcH5A, respectively; black arrowheads indicate E1 (Uba1), E3 and ubiquitin (Ub). In the case of TRIAD3A 
accumulation of di-ubiquitin (di-Ub) is observed, indicated by a black arrowhead.
www.nature.com/scientificreports/
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species. Moreover, all the samples show some degree of intramolecular flexibility, reflected by the upturn of the 
Krakty plots at higher q·Rg values. Interestingly, for TRIAD3A and RNF144A large changes in the shape of the 
Krakty plot and the P(r) are visible upon binding to UbcH7-Ub indicating clear changes in the overall shape 
of the particles and also that the intramolecular flexibility of the system is reduced. The overall conformational 
change, driven by E2-Ub binding, is smaller for HHARI and HOIP. The molecular weights derived from the 
Porod volumes and the ones obtained using the software SAXSMoW are in good agreement with molecular 
weights based on primary sequences indicating that the RBR domains and their complexes with UbcH7-Ub or 
UbcH5A-Ub are all monomeric in solution (Table 2).
Low-resolution envelopes were calculated for all of the samples by using the low-q region of the SAXS curve 
(see Table 2 for qmax values used in the analysis) (Fig. 5A–C,H,I,M–P). When analysing SAXS data, it is advanta-
geous to have structural models of the molecule of interest as this allows validation of the data by back-calculation 
of a theoretical SAXS curve from the structural model and comparison to the experimental curve. However, this 
approach is only possible when the molecule in solution populates a single conformation49. Crystal structures are 
available for HOIP and HHARI, although, the HHARI construct used in our analysis does not contain the inhib-
itory Ariadne domain that is present in all crystal structures, while the complex of HOIP with UbcH5B-Ub lacks 
electron density for a proportion of the LDD domain C-terminal to RING2. Moreover, as shown by the Kratky 
analysis, all our samples are flexible and therefore populate in solutions a number of different conformations in 
solution. Hence, it is not possible at present to generate structural ensembles that fit the SAXS data as this would 
require the a priori knowledge of the flexible residues in the different constructs. Therefore only a qualitative 
analysis of the low resolution molecular envelopes can be performed.
The envelopes of the apo-RBRs (Fig. 5A,G,M,O) are all elongated and those of HHARI and HOIP show the 
presence of two lobes, one larger than the other. The available crystal structures of HHARI in isolation (Fig. 5D, 
Figure 4. SAXS analysis of RBRs and their complexes with UbcH7~Ub and UbcH5A~Ub. Solvent-subtracted 
SAXS curves, Kratky plots and P(r) distributions are reported for HHARI, HHARI/UbcH7-Ub and HHARI/
UbcH5A-Ub (A,B,C); HOIP, HOIP/UbcH7-Ub and HOIP /UbcH5A-Ub (D,E,F), TRIAD3A and TRIAD3A/
UbcH7-Ub (G,H,I); RNF144A and RNF144A /UbcH7-Ub (J,K,L). The curves of RBRs in isolation are in grey, 
the curves of the complexes with UbcH7-Ub are in red and complexes with UbcH5A-Ub are in blue.
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PDB 4KBL) contain the full RBR domain together with the N-terminal UBA domain (grey surface, contoured 
by a black dashed line) and the auto-inhibitory Ariadne domain (cyan surface)10. The portion of the structure 
encompassing the UBA domain (Fig. 5D, circled in pink), RING1 (Fig. 5D, orange) and the IBR (Fig. 5D, green) 
looks strikingly similar to the large lobe of the envelope reported in Fig. 5A; therefore the smaller lobe of the 
HHARI-RBR envelope likely represent the location of RING2 that in the crystal structure (Fig. 5D, circled in 
purple) is in a different orientation probably because of the presence of the Ariadne domain. The structure of the 
HOIP-RBR domain (Fig. 5J) derived from the HOIP/UbcH5B-Ub complex (PDB 5EDV) is compatible with a 
model in which the larger lobe of the HOIP-RBR envelope (Fig. 5G) represents the portion of the molecule that 
contains the RING2-LLD domain (Fig. 5J, circled in purple), while the smaller lobe of the envelope represents the 
location of the RING1-IBR portion (Fig. 5J, circled in orange and green respectively). The molecular envelopes 
of isolated TRIAD3A (Fig. 5M) and RNF144A (Fig. 5O) also show an overall extended shape with three distinct 
regions that are reminiscent of the arrangement of the RING1, IBR and RING2 domains of one RBR polypeptide 
as seen in the crystal structure of the HOIP-RBR/UbcH5B-Ub complex.
In complex with UbcH7-Ub, the envelopes become larger, accounting for the presence of the E2-Ub, how-
ever, the elongated shapes are preserved in all cases (Fig. 5B,H,N,P). This set of envelopes shares similarities 
with the crystal structures of HHARI/UbcH7-Ub (Fig. 5E,F, PDB 5UDH and 5TTE respectively) and the 
extended-complex conformation observed in the HOIP/UbcH5B-Ub complex (Fig. 5K, PDB 5EDV)41–43. In 
those structures, the RBR domains are elongated with the E2s forming contacts with RING1 and the ubiquitin 
moieties being completely flexible (as in HHARI/UbcH7-Ub PDB 5UDH, Fig. 5E) or making some contacts with 
the RBR (as in HHARI/UbcH7-Ub PDB 5TTE or HOIP/UbcH5B-Ub PDB 5EDV, Fig. 5F and K respectively). An 
arrangement, in which the RBR is in an extended conformation and ubiquitin possess some degree of flexibility, 
would be in agreement with our ITC data that suggest that the binding to UbcH7-Ub is largely RING1/E2 driven 
Instrument SEC-SAXS at SWING beamline SOLEIL
SEC column Bio-SEC. 3 (Agilent)
q range (Å−1) 0.0022–0.62
Temperature 
(°C) 25 °C
Structural parameters
From ATSAS/PRIMUS From ScÅtter From DAMMIN
Sample Name
Sample 
Concentration 
(before SEC)
I(0) (cm−1/
absorbance) 
Reciprocal 
Space
Rg (Å) 
Reciprocal 
Space
I(0) (cm−1/
absorbance) Real 
Space
Rg (Å) Real 
Space Dmax (Å)
Porod Volume 
estimatea (Å3) NSD
b χ2b
Mw from 
Porod 
Volume 
(VPorod/1.6) 
(Da)
Mw from 
SAXSMoW 
(kDa)c
Mw from 
sequence 
(kDa)
HHARI-RBR 51 μM 0.007 31.0 0.00707 ± 0.00001 31.0 ± 0.1 112 67241 [qmax = 0.16]
0.63 ± 0.04 1.76 42025 42.0 35.8
HOIP-RBR 200 μM 0.088 31.4 0.08845 ± 0.00005 31.49 ± 0.05 130 66111 [qmax = 0.30]
0.58 ± 0.04 1.14 41320 42.5 43.4
TRIAD3A-RBR 200 μM 0.037 34.9 0.03730 ± 0.00003 34.93 ± 0.05 133 61443 [qmax = 0.21]
0.63 ± 0.02 2.38 38401 36.3 34.4
RNF144A-RBR 200 μM 0.029 29.7 0.02981 ± 0.00003 29.81 ± 0.05 110 44641 [qmax = 0.22]
0.61 ± 0.03 1.49 27900 26.6 29.0
HHARI-RBR/
UbcH7~Ub 48 μM 0.018 35.1 0.01839 ± 0.00004 35.2 ± 0.1 128
115384 
[qmax = 0.20]
0.58 ± 0.05 1.19 72115 75.3 62.5
HHARI-RBR/
UbcH5A~Ub 46 μM 0.013 34.0 0.01331 ± 0.00005 34.1 ± 0.2 128
87228 
[qmax = 0.18]
0.57 ± 0.07 2.52 54517 59.0 61.3
HOIP-RBR/
UbcH7~Ub 220 μM 0.13 36.7 0.1342 ± 0.0001 36.91 ± 0.09 138
118999 
[qmax = 0.18]
0.64 ± 0.06 0.54 74374 74.4 70.1
HOIP-RBR/
UbcH5A~Ub 220 μM 0.07 36.9 0.0728 ± 0.0001 37.1 ± 0.01 140
100170 
[qmax = 0.18]
0.58 ± 0.03 0.53 62606 74.4 68.9
TRIAD3A/
UbcH7~Ub 200 μM 0.08 37.6 0.08176 ± 0.00006 37.82 ± 0.06 151
86802 
[qmax = 0.22]
0.67 ± 0.03 2.58 54251 53.3 58.1
RNF144A-RBR/
UbcH7~Ub 200 μM 0.09 31.5 0.09292 ± 0.00004 31.64 ± 0.03 118
84561 
[qmax = 0.20]
0.50 ± 0.02 1.91 52850 54.9 55.7
Software employed
Primary data reduction Foxtrot
Data processing ATSAS and Scatter
Ab initio analysis DAMMIF/DAMMIN
Validation and averaging DAMAVER
Computation of model intensities CRYSOL
3D graphic representation PyMOL
Table 2. SAXS data-collection parameters. aThe Porod Volume estimation was carried out on truncated data to 
the highest value of q reported in square brackets. bValue derived from best DAMMIF model. chttp://www.if.sc.
usp.br/~saxs/.
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Figure 5. SAXS-derived envelopes and comparison with available crystal structures of HOIP/UbcH5B-Ub and 
HHARI/UbcH7-Ub. Low resolution SAXS-derived molecular envelopes for isolated RBRs domains (A,G,M 
and O) and their complexes with UbcH7-Ub and UbcH5A-Ub (B,C,H,I,N and P). Crystal structures of HHARI 
(PDB 4KBL) and HHARI/UbcH7-Ub (PDB 5UDH and 5TTE) are reported in panel D, E and F, respectively. 
The domains that constitute the RBR and E2-Ub are circled by dashed coloured lines, with UBA in pink, RING1 
in orange, IBR in green, RING2 in purple and UbcH7-Ub in red. The Ariadne domain, missing in the construct 
used for SAXS analysis, is shown in cyan. A black dashed line contours the portions of the structures that span 
the same number of domains as in the construct used in our SAXS analysis. The structures of the RBR domain 
of HOIP, and the extended- and compact- conformations in presence of UbcH5B-Ub, derived from PDB 5EDV, 
are reported in (J–L). The RBR domains and the E2-Ub are circled by dashed coloured lines, with RING1 in 
orange, IBR in green, RING2 in purple and UbcH5B-Ub in blue. In the 5EDV structure, the RING2 of HOIP 
is poorly defined; therefore we have reconstructed the missing regions in yellow using the higher resolution 
crystal structure of RING2 reported in PDB 4LJQ.
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with only a small effect coming from ubiquitin. The envelopes of HHARI-RBR and HOIP-RBR in complex with 
UbcH5A-Ub are slightly more compact than the ones obtained in complex with UbcH7-Ub but surprisingly are 
still elongated, suggesting that even in the presence of UbcH5A-Ub the overall shapes of the complexes are more 
similar to the extended-complex conformation (Fig. 5K) than to the compact-complex conformation (Fig. 5L) 
observed in the HOIP/UbcH5B-Ub structure.
Overall, our SAXS analysis shows that RBRs in isolation and in complex with E2~Ub, are highly dynamic spe-
cies and populate mainly elongated conformations in solution. The observation that none of the available crystal 
structures of HHARI or for HOIP can fully recapitulate the SAXS envelopes calculated likely indicates that the 
available structures represent snapshots of a specific frozen conformation of complexes that otherwise possess a 
high intrinsic flexibility.
Discussion
Protein ubiquitination by RBR ligases occurs via a multi-step process that involves recognition of the E2~Ub 
thioester intermediate by the RING1 domain, followed by ubiquitin transfer from E2 to the active site cysteine 
in RING2 and subsequently onto a substrate. At present, it is unclear if the nature of the E2 may influence this 
process and if a general mechanism of ubiquitin transfer across RBR ligases exists. To gain further insight into 
this reaction we characterised the interaction and activity with two E2s: UbcH5, a promiscuous E2 that is often 
used in biochemical and structural studies and UbcH7, which is cysteine-specific and is the physiological E2 for 
some, and possibly all, RBRs8,32.
Binding studies between four different RBRs (devoid of any auto-inhibitory domains) and the E2s in their apo- 
and ubiquitin-conjugated states showed that UbcH7 is sufficient to form a stable complex with all RBRs tested and 
that ubiquitin conjugation only enhances affinity to a minor degree. This observed increase is likely due to weak 
ubiquitin binding sites present on RBRs, such as the site on RING2 and the preceding linker recently identified 
by Dove and colleagues on HHARI40 or the binding site located on the UBA domain of HHARI reported in both 
structures of a HHARI/UbcH7-Ub complex (PDB 5UDH and 5TTE)41,42. Interestingly, two distinct orientations 
for the ubiquitin moiety is seen in these structures further supporting the suggestion that ubiquitin possesses a 
high degree of flexibility in the complex with UbcH7-Ub and is not a key anchoring point for complex forma-
tion. In contrast, stable complexes with UbcH5 could only be observed for the E2-Ub conjugate in conjunction 
with HHARI and HOIP and absolutely required the IBR and RING2 domains in addition to the E2-recognising 
RING1 domain. These observations are in good agreement with recent structural studies: the HOIP/UbcH5B-Ub 
complex shows an intricate network of contacts between ubiquitin and the helices connecting RING1 and IBR, 
the IBR domain itself, the subsequent linker and RING2, and fully supports the notion that ubiquitin is a key 
component in this interaction43. Taken together, these results suggest that RBRs can employ two different mecha-
nisms to recognise E2~Ub conjugates: a mainly RING1/E2-driven recognition in the case of UbcH7 that appears 
conserved in the four different RBR ligases analysed here and a ubiquitin-driven recognition of UbcH5~Ub 
conjugates, at least in conjunction with HOIP and HHARI and possibly other RBRs. An exception to this obser-
vation is Parkin, which binds the ubiquitin-conjugated form of UbcH7 significantly stronger than the apo-form45. 
However, Parkin differs considerably from other RBR family members due to the intricate structural arrangement 
of its auto-inhibited form, in which the RING1 and RING2 domains are close in space and phosphorylation of 
the auto-inhibitory UBL domain and binding of phosphoUb are required to activate the molecule in an allosteric 
fashion. Different models for the structural changes accompanying Parkin activation have been put forward, 
including a recent model in which local conformational rearrangements may reveal novel ubiquitin-binding sites 
that recruit ubiquitin conjugated to the E2 and facilitate ubiquitin transfer in trans45. Such a mechanism may be 
unique to Parkin and not occur in other RBRs and may explain the observed differences in E2 recognition.
The reason why RBRs have evolved two different mechanisms of recognition for UbcH7 and UbcH5 conju-
gates is likely based on a fundamental difference between those E2s: UbcH5 is a promiscuous and reactive E2 that 
can discharge ubiquitin onto lysine or cysteine residues, while UbcH7 is only cysteine reactive, despite being able 
to bind canonical RING domains tightly34. Therefore, for UbcH7~Ub, interaction with RING1 is sufficient to pro-
mote transthiolation by simply bringing the ubiquitin moiety and the catalytic cysteine of RING2 into close prox-
imity. In contrast, for UbcH5, lysine reactivity needs to be suppressed and additional interactions are key to keep 
the conjugate in an open conformation that can only discharge ubiquitin onto the catalytic cysteine of RING2.
Surprisingly, given these clear differences in interaction, there is no associated pattern in terms of catalytic 
activity. We speculate that this might be due to a trade-off between the high affinity of UbcH7~Ub for RBRs that 
will ensure efficient complex formation, whereas the low affinity of UbcH5 will ensure efficient recycling. In fact, 
the high affinity of apo UbcH7 for RING1 domains seems counterproductive as the E2 would be expected to stay 
bound after the ubiquitin has been transferred and hence prevent the next round of ubiquitin transfer. However, 
it has been suggested that in cells the conjugated form of E2s is the predominant one because of efficient E1 
activity35,50,51. Hence, it is likely that UbcH7~Ub is recycled, after discharging, by mass action displacement. On 
the other hand, the low affinity of UbcH5~Ub for RBRs may lower the rate of the initial encounter but once the 
ubiquitin is transferred the extremely low affinity of UbcH5 for RING1 will ensure that the E2 dissociates quickly 
after ubiquitin transfer onto RING2 and the next transfer cycle can begin; of course also in this case the mass 
action displacement mechanism would still hold true.
Based on our interaction studies we expected that UbcH5 and UbcH7 would promote two different architec-
tures of the E3/E2~Ub transfer complex: an extended conformation obtained in presence of UbcH7-Ub and a 
more compact conformation stabilised by the extra contacts with ubiquitin when conjugated to UbcH5, as it has 
been observed in the HOIP/UbcH5B-Ub complex. Surprisingly, our SAXS analysis did not fully corroborate this 
scenario: while the complexes with UbcH7-Ub showed extended envelopes that are compatible with the absence 
of strong ubiquitin-RBR contacts, the envelopes of the UbcH5-Ub containing complexes looked highly similar. 
Nevertheless, our SAXS experiments revealed an important property of RBRs and their complexes with E2-Ub: 
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their intrinsic flexibility. RBRs in isolation and in complex with E2~Ub are flexible species and tend to populate 
mainly elongated conformations. It is tempting to speculate that the two RBR conformations seen in the crys-
tal structure of HOIP/UbcH5B-Ub, the extended and the compact conformation, could represent two possible 
states of the RBR/E2~Ub complex that rapidly convert into each other, with the elongated RBR conformation 
representing the initial E3/E2~Ub encounter complex and the closed conformation representing the ubiquitin 
transfer-competent intermediate, that however will be very short lived. This high level of flexibility likely explains 
why it has been so difficult to crystallize complexes of RBR domains in the active form, bound to the E2~Ub 
conjugate.
Taken together, the data presented here show that the interaction of RBRs with UbcH5 and UbcH7 occurs 
in different ways, likely driven by the need to supress lysine-reactivity of UbcH5 that otherwise would lead to an 
unproductive and potentially faulty encounter. UbcH7 has evolved to bind tightly to RING1 domains and further 
contacts with the conjugated ubiquitin are not required because transthiolation is the only reaction available, and 
this does not require activation as it is an equilibrium reaction. This may also explain why the ability of UbcH7 to 
form stable complexes with canonical RING domains does not need to be supressed: no catalytic cysteine is avail-
able and hence no unwanted side products can be formed. In contrast, any possible lysine reactivity of UbcH5 
must be prevented to ensure that the reaction proceeds via the E3~Ub intermediate and hence extra contacts with 
ubiquitin ensure that no closed conformations can be formed.
All E2s, apart from UbcH7, are lysine reactive. Some may adopt closed conformations of the E2~Ub conjugate 
to a higher extent than UbcH5, highlighting the importance of enforcing an open E2~Ub conformation in con-
junction with RBRs to ensure that the reaction proceeds via an E3~Ub intermediate to enable the ligase to transfer 
the ubiquitin onto the correct substrate and determine chain linkage specificity as in the case of HOIP or catalyse 
mono-ubiquitination as in the case of TRIAD3A and RNF144A.
Methods
Plasmids and protein purification. The proteins used in this work were all expressed in E.coli. The RBR 
domains of HOIP, HHARI and TRIAD3A were cloned in pET49b vector by using ligase-independent cloning 
(LIC). The RBRs were expressed as GST-fused proteins with a 3C-protease cleavage site between the tag and the 
protein of interest. The RBR from RNF144A was cloned into an in-house modified pET49 with an N-terminal 
hexa-histidine tag cleavable by 3C-protease. UbcH7 and UbcH5A in pGEX-6P1 were expressed as GST-fused 
proteins with a 3C-protease cleavage site. All plasmids were sequence-verified (http://www.sourcebioscience.
com/). All recombinant protein samples were expressed in BL21(DE3)Gold cells at 18 °C overnight using 1 mM 
IPTG. Protein samples were purified following a two-step purification protocol consisting of an affinity step 
(using either glutathione sepharose 4B or Ni-NTA), followed by removal of the tag using 3C-protease and a size 
exclusion step in 25 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP. Final protein samples were concentrated 
and flash frozen in liquid nitrogen. UbcH5A-Ub and UbcH7-Ub were prepared using E2s with the catalytic 
cysteine residue mutated into lysine as previously reported38.
Ubiquitination assays. Ubiquitination assays were carried out by mixing all components (E1, E2, E3 and 
Ub) and starting the reaction by adding ATP to a final concentration of 10 mM. Reactions were carried out at 
25 °C in a final volume of 100 uL at the following concentrations, 0.5 μM E1, 2 μM E2, 5 μM E3 and 50 μM Ub 
(unless otherwise stated). The reaction was carried in 25 mM Hepes pH 7.5, 150 mM NaCl and samples were 
taken after 10, 30 and 60 minutes and quenched by adding SDS-containing buffer. Some reactions were carried 
out for up to 2 hours. The samples were run on reducing SDS-gels, stained with Coomassie Blue, scanned and 
converted to grey-scale using Adobe Photoshop.
Isothermal titration calorimetry. ITC experiments were performed at 293 K using a Microcal iTC200 
calorimeter (Malvern). The protein solutions were prepared in buffer containing 25 mM Hepes pH 7.5, 150 mM 
NaCl, 0.5 mM TCEP. All experiments were performed by placing the solution containing E2 or E2~Ub in the 
cell at concentrations between 25–30 μM and the solution containing the RBR in the syringe at concentrations 
between 250–300 μM. For each titration 20 injections of 2 μL were performed. Integrated data, corrected for 
heats of dilution, were fitted using a nonlinear least-squares algorithm to a 1:1 binding curve, using the MicroCal 
Origin 7.0 software package. The fitting parameters are ΔH° (reaction enthalpy change in kcal·mol-1), Kb (equi-
librium binding constant in M−1), and n (number of binding sites). Each experiment was repeated at least twice 
and average values are reported in Table 1.
SEC-SAXS analysis. SAXS data were collected at SOLEIL Light Source on beamline SWING. In line 
SEC-SAXS was performed using an Agilent 1200 HPLC system equipped with a 2.4 mL Bio-Sec. 3 (Agilent) 
column. Data were recorded on a PCCD170170 (AVIEX) detector and with a ~5–17 keV energy range allow-
ing the collection of the angular range q between 0.0038–0.62 Å−1. Samples were loaded onto the size exclusion 
column previously equilibrated in 25 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP at a concentration of 
about 200 μM. The primary reduction of the SAXS data was performed using the software Foxtrot (http://www.
synchrotron-soleil.fr/Recherche/LignesLumiere/SWING). Data processing was carried out with ATSAS (http://
www.embl-hamburg.de/biosaxs/software.html) to obtain the radius of gyration (Rg), the maximum particle 
dimension (Dmax), the excluded particle volume (Vp) and the pair distribution function (P(r)). The program 
SCATTER was used to obtain the excluded particle volume (Vp). A low resolution three-dimensional ab initio 
model for all the samples was generated using the program DAMMIF, averaging the results of 25 independent 
runs using the program DAMAVER. CRYSOL was used to compare available structures with experimental scat-
tering profiles. The ab initio models were rendered with PyMOL.
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